Key Personel

Donovan B. Yeates, PhD

CEO and Chairman : Donovan B Yeates is a founder of KAER BioTherapeutics. He is an international authority in respiratory physiology and aerosol deposition. He has been CEO of BioTechPlex since its inception in 1997. Previously, he was a Senior Research Career Scientist in the Department of Veterans Affairs. At the University of Illinois at Chicago , he created a Section of Environmental and Occupational Medicine in the Department of Medicine and turned around a university-wide Occupational Health and Safety Center . He was a tenured Research Professor in the Department of Medicine as well as a Professor of Bioengineering at the University of Illinois at Chicago . Dr. Yeates is an emeritus professor with over 90 publications. He is a past president of the Chicago Thoracic Society and served on the Board of Directors of Illinois Biotechnology Organization (IBIO). His Ph.D. in medical biophysics was awarded by the University of Toronto .

Lid B. Wong, Ph.D.

Cofounder of KAER and BioTechPlex Corporations. He has been responsible for the development of multiple advanced technologies novel systems and assays. Dr. Wong together with Dr. Mao identified novel target sites for the treatment of inflammation in allergic asthma as well as the carrier for tranfecting the KBT1000 oligo. Dr. Wong serves as a member of a NIH review panel. Dr. Wong was an Associate Professor in Bioengineering and Research Assistant Professor of Medicine at the University of Illinois at Chicago . Dr. Wong received his Ph.D. in bioengineering from the University of Illinois at Chicago .

Hua Mao , M.D.,Ph.D.

Cofounder. Dr. Mao has broad in depth experience and knowledge in medicine, bioengineering, molecular biology, cellular signal transduction and biophotonics. Prior to joining BioTechPlex, Dr. Mao was a research scientist at Nanogen, where she had significant roles in the development of a biochip-based high throughput genetic disease screening platform. Dr. Mao together with Dr. Wong identified novel target sites for the treatment of inflammation in allergic asthma as well as the carrier for trasfecting the KBT1000 oligo. Hua Mao received her MD from Shanghai Medical School and Ph.D in Bioengineering from the University of Illinois at Chicago .

Board of Directors:

Chair: Donovan Yeates, Ph.D. CEO, KAER BioTherapeutics

Ian Wisenberg, BC., CPA, CFO, BIOCOM; Finance and Business Development

Stephen Chang, Ph.D. CEO, MultiCell Technologies, Inc; R&D and Business Development.

Anthony Hickey, Ph.D., CEO, Cirrus Pharmaceuticals; Pharmaceutics and Respiratory Drug Delivery

Scientific Advisory Board

Chair: Donvoan B. Yeates, Ph.D.

Lid B. Wong, Ph.D.

Hua Mao, M.D., Ph.D.